EQUIFAX INC·4

Feb 26, 8:30 PM ET

Wilbanks Laura Louise 4

4 · EQUIFAX INC · Filed Feb 26, 2019

Insider Transaction Report

Form 4
Period: 2019-02-22
Transactions
  • Award

    Stock Option/Right to Buy

    2019-02-22+8,7388,738 total
    Exercise: $149.53From: 2022-02-22Exp: 2025-02-22Common Stock (8,738 underlying)
  • Award

    Common Stock

    2019-02-22+1,5808,566 total
  • Award

    Stock Option/Right to Buy

    2019-02-22+7,2447,244 total
    Exercise: $138.45From: 2022-02-22Exp: 2025-02-22Common Stock (7,244 underlying)
  • Award

    Stock Option/Right to Buy

    2019-02-22+5,9955,995 total
    Exercise: $127.37From: 2022-02-22Exp: 2025-02-22Common Stock (5,995 underlying)
Holdings
  • Common Stock

    (indirect: By 401(k))
    936
Footnotes (3)
  • [F1]Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on 2/22/2022.
  • [F2]Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.
  • [F3]Annual equity grant pursuant to the Company's long-term incentive plan. The option vests 100% on 2/22/2022.

Documents

1 file
  • 4
    doc4.xmlPrimary